(Q44778916)

6 December 2017

title

Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study (English)

1 reference

idiopathic interstitial pneumonia

6 December 2017

main subject

venous thromboembolism

1 reference

based on heuristic

inferred from title

1 reference

2

1 reference

6 December 2017

Børge G. Nordestgaard

series ordinal

4

object named as

Børge G Nordestgaard

1 reference

6 December 2017

Birgitte F Sode

1

1 reference

6 December 2017

Sune F Nielsen

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

18 February 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

6 December 2017

published in

1 reference

6 December 2017

volume

181

1 reference

6 December 2017

issue

10

1 reference

6 December 2017

page(s)

1085-1092

1 reference

Factor V Leiden and the risk for venous thromboembolism in the adult Danish population

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Factor V leiden homozygosity, dyspnea, and reduced pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

From clot to collagen: coagulation peptides in interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Protein C anticoagulant system in patients with interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Activated protein C inhibits the expression of platelet-derived growth factor in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Mendelian randomization: nature's randomized trial in the post-genome era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

Diagnosis of interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200912-1951OC

10.1164/RCCM.200912-1951OC

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference